Is This Biotech Stock After Groundbreaking Approval?
A breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
Compounding is important for investors as it maximizes potential returns over time. Discover its significance in your investment strategy.
27,336 articlesA breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
A new round of claims alleges harassment at Carta, the private equity software unicorn valued near $7.4 billion. As m...
U.S.-listed XRP ETFs attracted $25.8 million in a single day, the strongest inflow since January, pushing total ETF i...
Nokia's CEO warns that companies using AI must rethink work processes as automation turns ideas into action faster, r...
An activist investor is pressing for board seats in a high-stakes proxy battle at Lululemon, highlighting questions a...
Through mid-May 2026, VXUS has risen about 10% year-to-date, narrowly surpassing the S&P 500’s roughly 8% gain. The m...
IDVO’s $445 million income engine is under renewed pressure as growth at Taiwan Semiconductor slows, raising question...
Klarna and Sezzle stand out in the evolving fintech scene, but they offer very different risk/reward profiles. This g...
As the gig economy matures, two tech leaders stand out: Uber Technologies and DoorDash. This guide breaks down which ...
Tech stocks whipped around in a seesaw session as AI optimism collided with inflation concerns; the live nasdaq compo...
A CNBC program features a tech CEO who says AI will replace junior staff and urges a tax on automation, triggering a ...
Fidelity’s Emerging Markets ETF has surged about 30% year-to-date, driven by chipmakers and Chinese tech names, yet r...